BC | bladder cancer |
BCG | bacillus Calmette–Guérin |
BRIDGE | Bladder Cancer Research Initiative for Drug Targets Germany |
CSS | cancer-specific survival |
DFS EAU |
disease-free survival European Association of Urology |
HPF | high power field |
LA | lymphocyte aggregates |
MD | medical doctor |
MIBC | muscle-invasive bladder cancer |
NMIBC | non-muscle-invasive bladder cancer |
OS | overall survival |
PFS | progression-free survival |
RFS | recurrence-free survival |
ROI | region of interest |
TILs | tumor-infiltrating lymphocytes |
TLS | tertiary lymphoid structures |
TURB | transurethral resection of the bladder |
WHO | World Health Organization |